[1] Chen KH, Guo X, Ma D, et al. Dysregulation of HSG triggers vascular proliferative disorders [J]. Nat Cell Biol, 2004, 6 (9):872-883. [2] Zorzano A. Regulation of mitofusin-2 expression in skeletal muscle [J]. Appl Physiol Nutr Metab, 2009, 34(3): 433-439. [3] Chen KH, Guo XM, Xiao RP, et al. Dysregulation of HSG triggers vascular smooth muscle cell growth[J]. Blood, 2002, 99(12): 4443-4448. [4] 李玉梅, 朱学慧, 袁恒杰, 等. 无创性延迟肢体缺血预适应对糖尿病大鼠心肌缺血/再灌注氧化损伤的影响 [J]. 中国临床药理学与治疗学, 2008, 13 (11): 1220-1225. [5] Shiels H, O'Connell A, Qureshi MA, et al. Stable microtubules contribute to cardiac dysfunction in the streptozotocin-induced model of type1 diabetes in the rat [J]. Mol Cell Biochem, 2007, 294 (1/2):173-180. [6] 陶静, 胡杰, 高琴, 等. 大豆异黄酮预防离体大鼠心肌缺血再灌注损伤 [J]. 中国临床药理学与治疗学, 2011, 16 (10): 1090-1095. [7] Guo YH, Chen KH,Wei G, et al. Overexpression of Mitofusin-2 inhibited oxidized low-density lipoprotein induces vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit [J]. Biochem Biophys Res commun, 2007, 363 (2): 411-417. [8] Bugger H, Abel ED. Mitochondria in the diabetic heart [J]. Cardiovasc Res, 2010, 88 (2): 229-240. [9] Shen T, Zheng M, Cao C, et al. Mitofusin-2 is a major determinant of oxidative stress-mediated heart muscle cell apoptosis [J]. Biol Chem, 2007, 282 (32): 23354-23361. [10] Dorn GW, Clark CF, Eschebacher WH, et al. MARF and Opa1 control mitochondrial and cardiac function in Drosophila [J]. Circ Res, 2011, 108 (1): 12-17. [11] Parra V, Eisner V, Chiong M, et al. Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis [J]. Cardiovasc Res, 2008, 77(2): 387-397. |